In the future, the promising bacterial species will be isolated and characterised for the design
of bacteriotherapy products.
Not exact matches
Our results have given us insights into new
bacteriotherapies for C. difficile infection and inflammatory bowel disease, and moreover suggest general strategies for developing these therapies for many other diseases,» said Vanni Bucci, PhD, first author
of the study and an assistant professor at the University
of Massachusetts at Dartmouth.
MDSINE is the first tool we've developed under the new BWH Precision Medicine Initiative, and we're releasing it as open source software in that hope that it will help to advance the
bacteriotherapy field,» said senior author Georg Gerber, MD, PhD, MPH, Assistant Professor in Computational Pathology at BWH and Co-Director
of the Massachusetts Host - Microbiome Center at BWH.
«Salmonella strains have a natural preference for infiltrating and replicating within the cancer cells
of a tumor, making the bacteria an ideal candidate for
bacteriotherapy,» said Robert Kazmierczak, a senior investigator at the Cancer Research Center and a post-doctoral fellow in the Division
of Biological Sciences in the MU College
of Arts and Science.
«
Bacteriotherapy is the use
of live bacteria as therapy to treat a medical condition, like cancer.»
The striking similarity
of the recipient's and donor's intestinal microbiota following after
bacteriotherapy suggests that the donor's bacteria quickly occupied their requisite niches resulting in restoration
of both the structure and function
of the microbial communities present.
Bacteriotherapy by way
of fecal transplantation can be used to treat recurrent CDAD, which is thought to reestablish the normal colonic microflora.
Fecal transplant, otherwise known as
bacteriotherapy, is the method
of introducing microbes from healthy donors into the gastrointestinal (GI) tract
of people suffering from severe stomach problems, such as recurrent C. difficile colitis.
Fecal
bacteriotherapy («stool transplant») can be effective in treating recurrent Clostridium difficile infection, but concerns
of donor infection transmission and patient acceptance limit its use.
RestorFlora is the first probiotic
bacteriotherapy product that has combined three
of the world's most well studied and widely used probiotic strains — Saccharomyces Boulardii, Bacillus Subtilis HU58 and Bacillus Clausii.
Fecal Transplant FMT, also known as fecal microbiota transplant, human probiotic infusion,
bacteriotherapy, and fecal transplant, is a powerful infusion
of healthy colon flora treatment which has been used to treat c diff, aka C difficile infections, inflammatory bowel disease, irritable bowel syndrome, autoimmune disease, dysbiotic gut flora as well as other conditions.